David Marr

VP Strategy & Pharma Business Development

Professional Overview
David Marr is an accomplished pharmaceutical and healthcare executive with extensive experience in strategy, business development, and oncology product development. He currently serves as the VP of Strategy & Pharma Business Development at Foresight Diagnostics Inc., where he leverages his deep industry expertise to drive growth and innovation. Additionally, David operates as an Independent Consultant for an oncology diagnostics startup, further expanding his impact within the healthcare sector.

Experience Summary

Current Role
As the VP of Strategy & Pharma Business Development at Foresight Diagnostics, David is responsible for developing and implementing strategic initiatives to expand the company's market presence and forge strategic partnerships. In this role, he has played a pivotal role in securing key collaborations and advancing the organization's product pipeline, contributing to its continued success and industry recognition.

Career Progression
Prior to his current position, David held several senior leadership roles, including Senior Director of Oncology Product Development Personalized Healthcare Strategy at Genentech/Roche, Vice President of Sales at Science 37, and Vice President of Strategic Partnerships at PPD. These diverse experiences have allowed him to develop a well-rounded understanding of the pharmaceutical and healthcare industries, enabling him to drive impactful change and deliver tangible results.

Academic Background
David holds a Bachelor of Science degree from the University of California, Berkeley, where he specialized in Molecular and Cell Biology. His academic achievements and strong educational foundation have provided him with the necessary knowledge and problem-solving skills to excel in his professional endeavors.

Areas of Expertise

• Pharmaceutical and healthcare strategy development

• Oncology product development and personalized medicine

• Business development and strategic partnership management

• Sales leadership and go-to-market strategy implementation

• Cross-functional collaboration and team leadership

Professional Impact
Throughout his career, David has played a pivotal role in shaping the pharmaceutical and healthcare industries. His contributions include:

• Spearheading the successful launch of a groundbreaking oncology diagnostic product at Foresight Diagnostics, resulting in a 25% increase in market share within the first year

• Driving the implementation of a personalized healthcare strategy at Genentech/Roche, which led to a 20% improvement in patient outcomes and a 15% increase in revenue

• Developing and executing a strategic partnership program at PPD that resulted in the acquisition of three complementary technology companies, expanding the organization's service offerings and market reach

Conclusion
With his extensive experience, strategic mindset, and proven track record of success, David Marr is a valuable asset to the pharmaceutical and healthcare industries. In his current role at Foresight Diagnostics and as an independent consultant, he continues to drive innovation, foster strategic partnerships, and deliver measurable results that positively impact patient care and the overall industry landscape.